WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2003008637) USE OF GENOTYPING IN THE INDIVIDUALIZATION OF THERAPY
Latest bibliographic data on file with the International Bureau   

Considered void 2003-10-22 00:00:00.0


Pub. No.:    WO/2003/008637    International Application No.:    PCT/CA2002/001103
Publication Date: 30.01.2003 International Filing Date: 17.07.2002
Chapter 2 Demand Filed:    10.02.2003    
IPC:
C12Q 1/68 (2006.01)
Applicants: XANTHUS LIFE SCIENCES, INC. [US/US]; 141 Portland Street, Cambridge, MA 02139 (US) (AE, AG, AL, AM, AT, AU, AZ, BA, BB, BE, BF, BG, BJ, BR, BY, BZ, CA, CF, CG, CH, CI, CM, CN, CO, CR, CU, CY, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, FR, GA, GB, GD, GE, GH, GM, GN, GQ, GR, GW, HR, HU, ID, IE, IL, IN, IS, IT, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MC, MD, MG, MK, ML, MN, MR, MW, MX, MZ, NE, NL, NO, NZ, OM, PH, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, SN, SZ, TD, TG, TJ, TM, TN, TR, TT, TZ, UA, UG, UZ, VN, YU, ZA, ZM, ZW only).
LEYLAND-JONES, Brian [CA/US]; (US) (For US Only)
Inventors: LEYLAND-JONES, Brian; (US)
Agent: OGILVY RENAULT; Suite 1600, 1981 McGill College Avenue, Montreal, Québec H3A 2Y3 (CA)
Priority Data:
60/305,630 17.07.2001 US
Title (EN) USE OF GENOTYPING IN THE INDIVIDUALIZATION OF THERAPY
(FR) UTILISATION DU GENOTYPAGE DANS L'INDIVIDUALISATION DES THERAPIES
Abstract: front page image
(EN)The invention relates to the individualization of therapy. More specifically, the present invention relates to the use of genotyping for the individualization of therapy and/or individualization of drug dosing. More specifically, the present invention relates to the use of genotyping in the individualization of therapy with a therapeutic agent or a class of therapeutic agents.
(FR)La présente invention concerne l'individualisation de thérapies. En particulier, l'invention concerne l'utilisation du génotypage dans l'individualisation de thérapies et/ou l'individualisation de posologies. En particulier, l'invention se rapporte à l'utilisation du génotypage dans l'individualisation des thérapies faisant appel à un agent thérapeutique ou à une classe d'agents thérapeutiques.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, OM, PH, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)